Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD	Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis	Not yet recruiting	Phase 4	2026-08-19		NCT07772609

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Göteborg University	174
Karolinska University Hospital	181
Norrlands University Hospital	8
Region Stockholm	164
Sahlgrenska University Hospital	158
Skane University Hospital	71
Skaraborg Hospital	4
Sundsvall Hospital	3
University Hospital, Linkoeping	50
Uppsala University Hospital	80

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Akademiska sjukhuset	Uppsala	Sweden	1
Karolinska University Hospital Huddinge	Huddinge	Sweden	1
Linköping University Hospital	Linköping	Sweden	3
Norrlands universitetssjukhus	Umeå	Sweden	1
Sabbatsbergs sjukhus	Stockholm	Sweden	1
Sahlgrenska University Hospital Mölndal	Mölndal	Sweden	1
Skaraborgs sjukhus	Skövde	Sweden	1
Skåne Universitetssjukhus	Malmö	Sweden	1
Sundsvalls sjukhus	Sundsvall	Sweden	1